Search details
1.
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Int J Clin Oncol
; 29(2): 232-240, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38157190
2.
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CML.
Cancer Sci
; 114(3): 995-1006, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36336963
3.
Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan.
Cancer Sci
; 113(12): 4258-4266, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35689544
4.
Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes.
Cancer Sci
; 113(4): 1377-1392, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34932235
5.
ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells.
Nat Chem Biol
; 16(11): 1208-1217, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32958952
6.
Post-marketing surveillance of carfilzomib in Japanese patients with relapsed or refractory multiple myeloma.
Future Oncol
; 18(24): 2661-2674, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35815645
7.
[Acute lymphoblastic leukemia with "masked" Philadelphia chromosome].
Rinsho Ketsueki
; 63(11): 1525-1529, 2022.
Article
in Japanese
| MEDLINE | ID: mdl-36476792
8.
[De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
Rinsho Ketsueki
; 63(12): 1643-1647, 2022.
Article
in Japanese
| MEDLINE | ID: mdl-36653137
9.
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol
; 192(1): 190-199, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33152120
10.
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Jpn J Clin Oncol
; 51(7): 1059-1066, 2021 Jul 01.
Article
in English
| MEDLINE | ID: mdl-33959770
11.
Fluorescent nanoparticle-mediated semiquantitative MYC protein expression analysis in morphologically diffuse large B-cell lymphoma.
Pathol Int
; 71(9): 594-603, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34171161
12.
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.
Int J Clin Oncol
; 26(11): 2142-2150, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34259983
13.
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.
Int J Clin Oncol
; 26(11): 2131-2141, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34363558
14.
Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor.
Cancer Sci
; 111(10): 3714-3725, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-33404088
15.
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.
Cancer Sci
; 111(2): 749-759, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31849147
16.
Anaplastic large cell lymphoma with TP63 rearrangement: A dismal prognosis.
Pathol Int
; 69(3): 155-159, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30719810
17.
[Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Rinsho Ketsueki
; 60(8): 932-943, 2019.
Article
in Japanese
| MEDLINE | ID: mdl-31484893
18.
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
Ann Hematol
; 97(11): 2081-2088, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-29946911
19.
[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects].
Rinsho Ketsueki
; 59(6): 669-674, 2018.
Article
in Japanese
| MEDLINE | ID: mdl-29973441
20.
[Human parvovirus B19-induced hemophagocytic lymphohistiocytosis and myocarditis in an adult patient with hereditary spherocytosis].
Rinsho Ketsueki
; 59(6): 682-687, 2018.
Article
in Japanese
| MEDLINE | ID: mdl-29973443